PT  - JOURNAL ARTICLE
AU  - Alexandre, Andrea M.
AU  - Scarcia, Luca
AU  - Consoli, Arturo
AU  - Sun, Wen
AU  - Xu, Yingjie
AU  - Huang, Xianjun
AU  - Chung, Charlotte
AU  - Sgreccia, Alessandro
AU  - Abdalkader, Mohamad
AU  - Limbucci, Nicola
AU  - Pedicelli, Alessandro
AU  - De Leoni, Davide
AU  - Ganimede, Maria P.
AU  - Gaudino, Chiara
AU  - Russo, Riccardo
AU  - Papagiannaki, Chrysanthi
AU  - Partesano, Roberta
AU  - Mandruzzato, Nicolò
AU  - Gabrieli, Joseph D.
AU  - Panni, Pietro
AU  - Zini, Andrea
AU  - Clarençon, Frédéric
AU  - Raz, Eytan
AU  - Nguyen, Thanh N.
AU  - Broccolini, Aldobrando
AU - Collaborators of the emergent IntraCranial Artery Stenting (eICAS) international study group
TI  - Safety of emergent intracranial stenting after thrombolysis: a multicenter matched analysis
AID  - 10.3174/ajnr.A8918
DP  - 2025 Jul 09
TA  - American Journal of Neuroradiology
PG  - ajnr.A8918
4099  - http://www.ajnr.org/content/early/2025/07/09/ajnr.A8918.short
4100  - http://www.ajnr.org/content/early/2025/07/09/ajnr.A8918.full
AB  - BACKGROUND AND PURPOSE: In patients with acute large vessel occlusion (LVO) of the MCA and underlying intracranial artery stenosis (ICAS), rescue stenting (RS) has been associated with better angiographic outcomes and higher rates of functional independence compared to mechanical thrombectomy (MT) alone. However, uncertainty exists regarding safety of RS in patients at higher risk for intracranial bleeding.The primary aim of this retrospective multicenter study was to compare safety outcomes between patients with acute ICAS-LVO of the MCA who underwent MT and RS with or without prior intravenous thrombolysis (IVT). Efficacy outcomes were assessed as a secondary aim.METHODS: We screened the prospective databases of 26 stroke centers across Europe, the United States, and China for consecutive patients with acute MCA ICAS-LVO who received RS. Patients were divided into two groups based on prior administration of IVT: IVT/RS and no-IVT/RS. Propensity score matching (PSM), based on a set of covariates that also included peri-procedural antiplatelet therapies, was used to estimate the effect of IVT treatment. Primary safety outcomes were the occurrence of symptomatic intracranial hemorrhage (sICH) and 90-day mortality.RESULTS: After PSM, 52 pairs of patients were available for analysis. No significant differences were observed between the two groups regarding rates of sICH (11.5% in IVT/RS group vs. 9.6% in no-IVT/RS group, OR 1.2, 95% CI 0.4-4.3, p = 0.75) and 90-day mortality (14.3% in the IVT/RS group vs. 11.7% in the no-IVT/RS group, OR 1.3, 95% CI 0.4-4.2, p = 0.71). There were also no significant differences in the occurrence of parenchymal hemorrhage types 1 and 2, successful recanalization rates and 90-day functional outcome.CONCLUSIONS: The safety of RS in ICAS-LVO is not significantly affected by prior IVT administration. Furthermore, IVT does not result in improved recanalization and clinical outcome. These findings should be interpreted with caution and require validation through future randomized controlled studies.ABBREVIATIONS: MT＝ mechanical thrombectomy; LVO＝ large vessel occlusion; ICAS = intracranial artery stenosis; RS = rescue stenting; IVT = intravenous thrombolysis; sICH = symptomatic intracranial Hemorrhage; PH = parenchymal hematoma; SD = standard deviation; IQR = interquartile range; PSM = propensity score matching; SMD = standardized mean difference; OTG = onset-to-groin; GPI = glycoprotein IIb/IIIa inhibitors.